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Abstract
Background: The pathology of Parkinson’s disease (PD) is characterized by the degeneration of the nigrostriatal
dopaminergic pathway, as well as the formation of intraneuronal inclusions known as Lewy bodies and Lewy neurites in the
substantia nigra. Accumulations of nitrated a-synuclein are demonstrated in the signature inclusions of Parkinson’s disease.
However, whether the nitration of a-synuclein is relevant to the pathogenesis of PD is unknown.
Methodology/Principal Findings: In this study, effect of nitrated a-synuclein to dopaminergic (DA) neurons was
determined by delivering nitrated recombinant TAT-a-synuclein intracellular. We provide evidence to show that the nitrated
a-synuclein was toxic to cultured dopaminergic SHSY-5Y neurons and primary mesencephalic DA neurons to a much
greater degree than unnitrated a-synuclein. Moreover, we show that administration of nitrated a-synuclein to the substantia
nigra pars compacta of rats caused severe reductions in the number of DA neurons therein, and led to the down-regulation
of D2R in the striatum in vivo. Furthermore, when administered to the substantia nigra of rats, nitrated a-synuclein caused
PD-like motor dysfunctions, such as reduced locomotion and motor asymmetry, however unmodified a-synuclein had
significantly less severe behavioral effects.
Conclusions/Significance: Our results provide evidence that a-synuclein, principally in its nitrated form, induce DA neuron
death and may be a major factor in the etiology of PD.
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Introduction
Parkinson’s disease (PD) is characterized by the progressive
degeneration of the nigrostriatal dopaminergic pathway, as well as
the formation of neuronal inclusions known as Lewy bodies and
Lewy neurites within DA neurons of the substantia nigra [1].
Although most cases of PD are sporadic, a number of genes have
been linked to familial forms of PD. Among these, the a-synuclein
gene has received much attention. Missense mutations in a-
synuclein and duplications or triplications of the locus cause PD
[2–7]. a-Synuclein is involved in dopamine neurotransmission,
including release and reuptake [8,9], and also affects enzymes
involved in chromatin remodeling [10]. a-Synuclein comprises a
major component of Lewy bodies and Lewy neurites in DA
neurons in the substantia nigra of patients with PD, and is a major
constituent of other types of inclusions found in a group of
diseases, collectively known as ‘synucleinopathies’ [11]. Overex-
pression of a-synuclein in the nigrostriatal system induces PD-like
neurodegeneration [12]. The production of a-synuclein in
transgenic mice [13], flies [14] or primates [15] leads to motor
deficits and neuronal inclusions reminiscent of PD.
Reactive oxygen and nitrogen species are thought to be pivotal
to DAergic-specific neurotoxic processes in PD [16,17]. Peroxyni-
trite (ONOO
2), a stable reactive nitrogen species, is a potent
oxidant formed by the reaction of nitric oxide with superoxide
anions and has been shown to selectively nitrate protein tyrosine
residues [18]. Protein nitration and consequent alterations in
function are implicated as important contributors to cell
dysfunction and apoptosis in neurodegenerative pathologies [19].
By exposing DAergic cells to pan-nitrating reagents, certain
nitrated proteins have been detected in DA neurons, including
protein kinase C [20], catecholamines [21], manganese superoxide
dismutase [22], a-synuclein [23–25], which demonstrated the
possible importance of nitrated stress in the etiology of PD both in
vitro and in vivo. However, it remains unclear which specific
nitrated proteins are toxic to DAergic cells, and contribute to the
development of PD.
Previous reports have shown that nitrated a-synuclein was
detected in brain tissue from individuals with synucleinopathy,
indicating a direct link between oxidative and nitrative damage to
the onset and progression of neurodegenerative synucleinopathies
[23]. However, the exact role of nitrated a-synuclein in the
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show that the nitrated form of a-synuclein is significantly more
toxic to DA neurons, both in vitro and in vivo. Furthermore, we
show that exposing the substantia nigra to nitrated a-synuclein
causes motor defects reminiscent of PD. These results provide
compelling insight into the development of synucleinopathies in
general, and PD in particular.
Materials and Methods
Cloning and preparation of nitrated protein
a-Synuclein cDNA (SNCA112) was generated by PCR from a
human brain cDNA library (Clontech, Palo Alto, CA) and inserted
into pHA-TAT expression vector (kindly provided by Dr. Steven F
Dowdy) that contains a HA-tag in frame with the TAT
internalization signal peptide, to generate HA-TAT-a-synuclein
(herein refered to as SYN). a-Synuclein lacking the TAT peptide
(SYN
TAT2) was created by amplifying a-synuclein cDNA and
cloning it into a pet28a expression vector (Novagen). Full-length
eGFP cDNA, amplified from pEGFP-N1 (Clontech, Palo Alto,
CA), was subcloned into pHA-TAT expression vector to generate
HA-TAT-eGFP (GFP). All constructs were fully sequenced.
Recombinant proteins were expressed and purified using standard
techniques [26].
Protein nitration was performed as previously reported, with
some modifications [27,28]. Briefly, proteins suspended in PBS
[pH 7.4] were incubated with 1 mM 3-morpholinosydnonimine
(SIN-1; Sigma-Aldrich, St. Louis, MO, USA) at 37uC for 3 h, then
dialyzed in PBS for 24–48 hours with multiple exchanges of PBS.
Samples of purified SYN and nitrated-SYN (N-SYN) proteins
were fractionated using 15% SDS-PAGE, and stained with
Brilliant Coomassie Blue, or detected by immunoblotting with
anti-HA antibody (1:3000, Roche, Indianapolis, IN, USA) or
monoclonal mouse anti-Nitrotyrosine antibody (1:2000, Upstate,
Temmecula, CA, USA). After incubation with horseradish
peroxidase (HRP)-conjugated secondary antibodies (Sigma;
1:10,000), protein bands were visualised by chemiluminescence
(ECL Western Blotting kit, Amersham). Coomassie Blue-stained
protein corresponding to the theoretical molecular weight of SYN
(,20 kD) were excised from gels and stored at 280uC before
MALDI-TOF/TOF MS analysis.
MALDI-TOF/TOF MS analysis
In-gel tryptic digest and mass spectrometry (MS) were
performed at the Institute Mass Spectrometry Facility (University
of Fudan, Shanghai, China). Briefly, SYN and N-SYN in SDS-
PAGE were transferred to 96-well microplates loaded with 100 ml
of 50% Acetonitrile (ACN)/25 mM ammonium bicarbonate
solution per well. After destaining for 1 h, gel plugs were
dehydrated with 100 ml of 100% ACN for 20 min and then dried
thoroughly in a SpeedVac concentrator (Thermo Savant, USA)
for 30 min. The dried gel particles were rehydrated at 4uC for
45 min with 2 ml/well trypsin (12.5 ng/ml, Promega, Madison,
WI, USA) in 25 mM ammonium bicarbonate, and then incubated
at 37uC for 12 h. After trypsin digestion, the peptide mixtures
were extracted with 100 ml extraction solution (50% ACN/0.1%
TFA) per well at 37uC for 1 h. Finally, the extracts were dried
under the protection of N2.
Peptides were eluted with 0.5 ml matrix solution (a-cyano-4-
hydroxy-cinnamic acid (CHCA, Sigma-Aldrich, St. Louis, MO,
USA) in 50% ACN/0.1% TFA) before spotting onto target plates.
Samples were allowed to air-dry and then analyzed using a 4700
MALDI-TOF/TOF Proteomics Analyzer (Applied Biosystems,
CA, USA). Trypsin-digested myoglobin was used to calibrate the
mass instrument. All acquired samples spectra were processed
using the default mode of 4700 ExploreTM software (Applied
Biosystems, CA, USA). Parent mass peaks with a mass range 700–
3200 Da and a minimum S/N of 20 were picked out for tandem
TOF/TOF analysis. The theoretical molecular mass (m/z) was
determined using an ExPASy-computed peptide-mass tool pro-
gram (http://www.expasy.org/tools/peptide-mass.html), and the
following parameters: trypsin digest with one missing cleavage,
possible oxidation of methionine (MSO), cysteines in reduced
form, peptides with a mass bigger than 500 Da, monoisotopic
masses of the occurring amino acid residues, and peptide masses as
[M+H]
+.
SHSY-5Y and primary ventral mesencephalon cultures
and immunocytochemistry
SHSY-5Y DAergic human neuroblastoma cells, kindly provided
by Dr. Zhou JW, were cultured at 37uC, 5% CO2 and 95%
humidity in Dulbecco’s Modified Eagles Medium (DMEM) + F12
(1:1) (Invitrogen, Grand Land, USA) containing 10% fetal bovine
serum. Having grown to 80% confluence, cells were transferred
onto glass cover slips at a density of 1610
5 and kept overnight.
The ventral part of the midbrain was dissected from embryonic
day 16 (E16) Sprague-Dawley rats and dissociated in Hanks
balanced salt solution (HBSS) containing 0.125% trypsin (GIBCO,
Canada) for 20 min at 37uC. Tissues were resuspended in DMEM
containing 10% fetal bovine serum (FBS) (BIOSOURCE, Brazil)
and 10% horse serum (HS) (GIBCO, Canada), Cells were seeded
at 5610
5/well onto poly-L-lysine (20 mg/mL) precoated cover
slips in 24-well culture plates and maintained at 37uCi na
humidified atmosphere of 5% CO2 and 95% air, and then
switched 12 hours later to serum-free Neurobasal medium
(GIBCO, Canada) containing B27 supplement (GIBCO, Canada).
Cells cultured on poly-L-lysine-coated glass coverslips were
fixed with 4% paraformaldehyde/PBS solution for 20 min,
permeabilized using 0.1% Triton X-100 and 0.2% FBS in PBS
for 15 min, and incubated overnight with anti-Tyrosine hydrox-
ylase (TH) antibody (1:6000, Sigma-Aldrich, St. Louis, MO, USA)
in PBS with 1% horse serum at 4uC. After washing with PBS, cells
were incubated with FITC- or rhodamine-conjugated secondary
antibodies (1:200, Jackson Immuno Laboratories, West Grove,
PA, USA) for 1 h at RT, washed again, and counterstained with
Hoechst 33258 (Sigma-Aldrich, St. Louis, MO, USA) for 15 min
at RT. Cells were visualized and imaged under an inverted
fluorescence microscope (DXM1200, Nikon, Inc., Japan).
To calculate the number of TH-immunoreactive primary
neurons on each coverslip, TH-positive cells in at least ten
randomly chosen observation fields were counted in each of three
independent cultures derived from three individuals for each
experimental condition. The data were then expressed as the
percentage of TH-positive neurons in SYN, N-SYN or N-GFP
treated cultures relative to PBS-treated cultures. At least nine
coverslips were counted in each group. Over 3000 DA neurons
were counted.
LDH cytotoxicity assay
Cellular toxicity was evaluated by measuring lactate dehydro-
genase (LDH) activity in the medium at each indicated time point
after exposure to the CytoTox96 nonradioactive assay (Promega,
Madison, WI, USA). LDH activity was then quantified by
measuring wavelength absorbance at 490 nm according to the
manufacturer’s protocol. Data were averaged across three
independent experiments, normalized to the amount of LDH
released from lysed cells at each time point, and corrected for
baseline LDH release from non-treated cells exposed to PBS.
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TUNEL staining was performed using the In Situ Cell Death
Detection Kit, TMR red (Roche, Mannheim, Germany) accord-
ing to the manufacturer’s instructions. The number of TUNEL-
positive was normalized to the total number of Hoechst labeled
cells and averaged across three independent experiments, as
described previously [29].
Animal surgery
All animal experiments were carried out in adherence with the
National Institutes of Health Guidelines on the Use of Laboratory
Animals and approved by the Second Military Medical University
Committee on Animal Care. A stainless-steel guide cannula was
stereotaxically implanted into the right substantia nigra pars
compacta (SNpc) of adult male Sprague-Dawley rats (200–230 g)
using the following coordinates: anteroposterior (AP) 24.8 mm;
lateral (L), +2.0 mm; and dorsoventral (DV), 27.0 mm, and using
the bregma as the starting point. Each rat then received infusions
of 2 mlo f2 0mM N-SYN, SYN or N-GFP at a rate of 0.5 ml/min
everyday for two weeks. Another group of rats were administered a
single injection of 2 ml 6-OHDA (10 mg/ml, Sigma-Aldrich, St.
Louis, MO, USA) dissolved in 0.02% ascorbate/saline using the
same coordinates: anteroposterior (AP) 24.8 mm; lateral (L),
+2.0 mm; and dorsoventral (DV), 27.0 mm, and using the
bregma as the starting point. This group was included as a
positive control.
To evaluate the effects of the treatments, rats were acclimatized
for 15 min in a 30 cm diameter, hemispherical pot, and then
subcutaneously injected with apomorphine (APO, 0.5 mg/kg in
saline; Sigma-Aldrich, St. Louis, MO, USA). Post-injection
rotations were counted over 30 min, and visual behavioral
assessments were made using video-recorded observations.
Behavioral tests
Open-field activity was observed in automated activity cages.
Rats were adapted daily to the open-field test for one week
preceding the injections. Tests were performed at the same time
(between 3:30 p.m. and 5:30 p.m.) after 21 days post-surgery.
Locomotor activity was recorded by video tracking. The behavior
was videotaped for 15 minutes, and the following parameters were
recorded: total distance traveled, distance traveled in the center of
the field, distance traveled in the periphery, and active time. The
scoring was calculated as mean 6 SEM. Statistical significance
was tested using two-way ANOVA analysis.
The rotorod test was conducted 1 day before and 21 days after
stereological surgery, using a standard rotorod apparatus (Dig-
Beha-RRTM, JLsofttech, Shanghai). The parameters of rotorod
system include start speed, acceleration and highest speed (3 rpm,
accelerate 1 rpm/24 s, 8 rpm). Rats that were unable to stay on
the rod for 2 min over 3 trials were excluded from further
experimentation. Each rat was placed on the confined section of
the rod and was recorded over three consecutive trials with a
2 min rest between each trial. The mean latency to fall for the
three trials, measured both as a function of time (sec) and rod
velocity (rpm), was used for analysis. In all trials, if the rat did not
fall from the rod after 2 min, it was removed.
Isolation and Processing of Tissues
It was performed according to the previous protocol [30].
Briefly, rats were deeply anaesthetized with sodium pentobarbital
(40 mg/kg i.p.). Brains were removed and divided into two parts
by a coronal blade cut at approximately 23.5 mm behind
bregma. The caudal part containing the SNc was fixed in the
ice-cold 4% paraformaldehyde in 0.1 M phosphate buffer (PB),
pH 7.4. The rostral piece of brain tissue was used immediately to
dissect the right and left striatum. The striatum from each
hemisphere was homogenized and separated into two separate
tubes. The tissue pieces were weighed, frozen separately on dry
ice, and kept at 280uC until assayed for protein expression or
dopamine (DA) and 3–4-dihydroxyphenylacetic acid (DOPAC)
content. The fixed part of brains were stored overnight at 4uC and
then transferred into 20% sucrose in 0.1 M PB for cryoprotection.
Coronal sections (20 mm thick) were cut on a freezing stage sliding
microtome (CM1900, Leica, Germany) and processed for
immunohistochemistry.
Immunohistochemistry
A series of the total sections throughout the substantia nigra
were mounted onto gelatinized slides, incubated with antibody
against TH (1:6000; Sigma-Aldrich, St. Louis, MO, USA), HA
(1:1000; Abcam, Hong Kong, China), GAD (1:1000; Sigma-
Aldrich, St. Louis, MO, USA ), GFAP (1:200; Sigma-Aldrich, St.
Louis, MO, USA), a-synuclein (2E3, 1:1000; kindly provided by
Prof. Chan P) [31] or Iba-1 (1:500; Abcam, MA, USA) overnight
at 4uC, followed by incubation with FITC-conjugated donkey
secondary anti-mouse antibody (1:200; Jacksonimmuno, West
Grove, PA, USA), TRITC-conjugated donkey secondary anti-
mouse antibody (1:200; Jacksonimmuno, West Grove, PA, USA),
TRITC-conjugated donkey secondary anti-rabbit antibody (1:200;
Jacksonimmuno, West Grove, PA, USA) or TRITC- conjugated
donkey secondary anti-goat antibody (1:200; Jacksonimmuno,
West Grove, PA, USA) for 1 h at room temperature. Sections
were then counterstained with Hoechst to stain the nuclei. One set
of TH immunostaining sections were counterstained with Nissl
staining. As a negative control, the primary antibody step was
omitted, no staining was observed (data not shown). For double
labeling with immunohistochemistry and Thioflavin-T to detect
aggregation, sections containing the substantia nigra were
incubated with antibody against a-synuclein (2E3, 1:1000; kindly
provided by Prof. Chan P) overnight at 4uC, followed by
incubation with TRITC-conjugated donkey secondary anti-mouse
antibody (1:200; Jacksonimmuno, West Grove, PA, USA) for 1 h
at room temperature. After subsequent washes, sections were then
incubated 8 min with a 0.05% Thioflavin-T solution according to
the method described by Albani D [32]. Staining was analyzed
and photographed under fluorescence microscopy (DXM1200,
Nikon, Inc., Japan) using proper optical filters. As a negative
control, the secondary antibody step or the Thioflavin-T step was
omitted, and no optical crosstalk was detected (data not shown).
Cell counting
Cell counting was performed according to the previous protocol
with minor modification [33]. Briefly, by applying anti-HA
antibody, the anterior and posterior boundaries of the substantia
nigra included in the analysis were defined according to the area
transduced by HA-TAT-SYN (SYN) in preliminary experiments
[approximately anteroposterior (AP) 24.4 mm through 26.0 mm
from bregma]. Sections included in the analysis throughout the
substantia nigra were analyzed stereologically. Each section was
first viewed at low magnification (46). The third cranial nerve, a
line between the medial lemniscus and the tractus opticus basalis,
or a line extending dorsally from the most medial boundary of the
cerebral peduncle were used as a landmark to define the vertical
border between the substantia nigra and the ventral tegmental
area; and the medial lemniscus was used as the dorsal border, as
described previously [34]. The number of TH-positive cells was
counted using higher magnification (206,4 0 6). To avoid double
TAT-N-SYN Damages DA Neurons
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labeled cells were counted only when their nuclei could be
distinctly visualized.
Anti-D2 Western blot
Striatal tissue from treated rats was homogenized on ice in
RIPA (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.1% SDS, 1%
Triton X-100, 0.5% deoxycholic acid sodium, 1% NP-40, 0.02%
NaN3) containing a protease inhibitor cocktail (Roche, Germany),
followed by centrifugation at 12,000 g for 15 min at 4uC. The
supernatant was then separated by 15% SDS-PAGE electropho-
resis and immunoblotted with anti-D2 receptor (1:100; Millipore,
USA), anti-TH (1:8000; Sigma-Aldrich, St. Louis, MO, USA) and
anti-GAPDH (1:10000; KANGCHEN, China) antibodies. Protein
bands were visualized by chemiluminescence (ECL Western
Blotting kit, Amersham), analysed using Image-Pro Plus software,
and expressed as band intensities relative to the GAPDH band in
the same lane.
Determination of Dopamine Content in striatum by HPLC
Striatal levels of dopamine (DA) and 3,4-dihydroxyphenylacetic
acid (DOPAC) were measure by HPLC at the Institute of
Neuroscience (Chinese Academy of Sciences, Shanghai, China).
Briefly, striatal tissues taken from N-SYN, SYN and N-GFP
groups 5 weeks post surgery were homogenized in 0.2 M
perchloric acid. Insoluble debris was removed by centrifugation
at 20,000 rpm for 10 min, and the supernatant was filtered
through a Millipore MC cartridge. The filtrate was injected on a
C18 reverse phase column (Capcell PAK C18 MgII) and analyzed
by HPLC with electrochemical detection (ESA, Bedford, MA).
The levels of DA, DOPAC in ipsilateral striatum were expressed
as a percentage of that in contralateral striatum.
Statistical Analysis
All values are expressed as mean 6 SEM. Differences among
means were analyzed by one-way ANOVA followed by Tukey
post hoc test for pairwise comparison unless otherwise stated.
Results
Preparation and identification of nitrated a-synuclein
Purified a-synuclein fused to TAT-HA (SYN) was exposed to 3-
morpholinosydnonimine (SIN-1), a putative nitrating agent that
selectively nitrates tyrosine residues [19,28,35]. Coomassie Blue R-
250 staining revealed that SYN exposed to SIN-1 (N-SYN)
separated in SDS-PAGE as a single band with a molecular weight
similar to untreated SYN (Figure 1A, top). Anti-HA Western
blotting further confirmed that treating SYN with SIN-1 did not
change the electrophoretic properties of SYN, and showed that the
N-SYN product is slightly larger than SYN (Figure 1A, middle).
The nitration of a-synuclein induced by SIN-1 was confirmed with
an anti-nitrated tyrosine (NT) Western blot (Figure 1A, bottom).
a-Synuclein has three potential nitrate acceptor tyrosine sites.
To determine which residue(s) had been nitrated, SYN and N-
SYN bands in SDS-PAGE were solubilized and analyzed by
MALDI-TOF/TOF MS. Unmodified SYN (theoretical m/z:
19806) produced a prominent peak (m/z: 19682.10, with a mass
accuracy of 0.6%) unique from the prominent peak observed (m/
z: 19846.25) for SIN-1-treated SYN (theoretical m/z: 19806+45n,
where 1#n#8, Figure 1B). The difference in masses between these
two peaks, equal to unmodified a-synuclein plus the equivalent
mass of three nitrate groups, indicates that all three tyrosine
residue acceptor sites in the SYN protein possibly had been
nitrated.
Peptides obtained by MS analysis that matched a-synuclein
sequence fragments (Figure 1C) are listed in Figure 1D. Among
the fragments obtained from nitrated and unmodified SYN
(Figure 1D), the mass signal corresponding to residues 103–112
was increased from 1200.4962 m/z to 1291.5127 m/z, and the
signal corresponding to residues 35–43 increased from
951.5442 m/z to 996.2355 m/z (Figure 1E). These results
indicate that incubating purified SYN with SIN-1 leads to the
nitration of both tyrosine residues within the Glu
103-Ala
112
fragment (Tyr 105 and Tyr 108), as well as the single tyrosine
residue within the Glu
35-Lys
43 fragment (Tyr 39; Figure 1F).
Nitrated a-synuclein is sufficient to induce neurotoxicity
in vitro
To evaluate the survival of DA neurons exposed to SYN or N-
SYN, we incubated human DAergic SHSY-5Y cells with different
concentrations (0.1 mM–1 mM) of nitrated or unnitrated TAT-
fused SYN. The intracellular localization of N-SYN in SHSY-5Y
cells was confirmed by anti-HA immunocytochemistry. Consistent
with previous reports [36], the TAT motif facilitated the
internalization of SYN into the cytoplasm of almost all cultured
cells. N-SYN was also effectively directed to the intracellular space
of SHSY-5Y cells, indicating that nitrating does not affect
internalization and demonstrating that all three fusion proteins,
including SYN, N-SYN, and a nitrated form of eGFP also fused to
TAT-HA (N-GFP); can localize to the cytoplasm (Figure 2).
Cytotoxicity was then determined using a lactate dehydrogenase
(LDH) release assay. At low concentrations (from 0.1 to 0.5 mM),
neither SYN nor N-SYN caused increases in LDH release from
SHSY-5Y cells relative to N-GFP, at any time point up to 108 h of
observation. However, within 24 h of applying 1 mM N-SYN, but
not SYN, there was a significant increase in LDH release that
continued to rise over time relative to N-GFP control and SYN
levels, indicating a dramatic cytotoxic effect (Figure 3A).
To determine whether cytotoxicity was dependent on the uptake
of N-SYN into the cell, we exposed SHSY-5Y to nitrated or
unnitrated SYN fusion proteins lacking the TAT peptide, SYN
TAT-.
Removing the TAT peptide completely eliminated the increase in
LDH release, showing that intracellular, but not extracellular, N-
SYN is deleterious to cell survival (Figure 3B). This finding also
shows that the observed cytotoxicity was not due to secondary
reactive nitrate species within the N-SYN solution, such as
peroxynitrite, since these are able to cross cell membranes [37].
N-SYN induces DAergic cell apoptosis in a
dose-dependent manner
SHSY-5Y cells exposed to SYN and N-SYN were TUNEL
labeled to assess cellular apoptosis (Figure 4). Apoptotic cells were
apparent 5 hours after application of 0.5 mM of N-SYN. 1 mMo f
N-SYN had a more dramatic effect, causing a more than 2-fold
increase in the percentage of apoptotic SHSY-5Y neurons in the
culture dish compared to N-GFP treated control neurons.
Although 1 mM SYN also increased the incidence of apoptotic
cell death, N-SYN was significantly more toxic at this concentra-
tion. Thus, nitrated a-synuclein is more toxic to human DAergic
SHSY-5Y cells than the unmodified form of the protein. To
determine if there was any correlation between protein aggrega-
tion and apoptotic cell death of SHSY-5Y cells, anti-HA antibody
was used to detect protein aggregation. Immunostaining with HA
and TUNEL revealed that some TUNEL positive apoptotic cells
contained intracellular aggregates (Figure S1, arrow), but some
apoptotic cells didn’t contain intracellular aggregates (Figure S1,
arrow head). Additionally, some cells contained HA positive
TAT-N-SYN Damages DA Neurons
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correlation between protein aggregation and apoptotic cell death
still need clarified.
Nitrated a-synuclein induces the death of primary ventral
mensencephalic DA neurons
To further assess neurotoxicity, dissociated primary ventral
mensencephalic (VM) cells from the brains of E16 rats were
exposed to N-SYN for 48 h, and TH-positive DA neurons were
counted. High concentrations of N-SYN (5 and 10 mM) were
found to be highly toxic, killing most cells, including glia (data not
shown). Lower concentrations, on the other hand, greatly reduced
the number of DA neurons in a dose-dependent manner (Figure 5).
Incubation with 0.1, 0.5 and 1 mM N-SYN reduced DA neurons
to 73.663.0%, 32.062.0% and 22.263.3%, respectively, com-
pared to control cultures treated with N-GFP (p,0.01). As
expected from previously published [32], 0.5 mM and 1 mM SYN
also reduced the number of DA neurons, however to a significantly
lesser degree than N-SYN (89.664.1%, 83.165.5% and
71.664.1% of control levels). These results demonstrate that
nitrated a-synuclein is more toxic to cultured ventral mensence-
phalic DA neurons than unmodified a-synuclein.
N-SYN leads to the death of DA neurons in the substantia
nigra pars compacta
To investigate the effect of N-SYN in vivo, we administered N-
SYN, SYN or 6-OHDA (a neurotoxin that selectively kills DA
neurons) into the ipsilateral substantia nigra pars compacta (SNpc)
of adult male rats and compared the number of DA neurons
therein with that in the contralateral SNpc after 5 or 11 weeks
(Figure 6). The intracellular localization of N-SYN in DA neurons
was confirmed by anti-HA immunohistochemistry. Consistent
with previous reports [36], the TAT motif facilitated the
internalization of SYN into the cytoplasm of almost all cells in
SNpc (data not shown). N-SYN was also effectively directed to the
intracellular space of DA neurons, indicating that nitration also
does not affect internalization in vivo (Figure 7). As shown in
Figure 8, a single injection of the positive control 6-OHDA (2 mlo f
Figure 1. Purification and identification of nitrated a-synuclein. (A) Unnitrated (SYN) and nitrated (N-SYN) a-synuclein TAT-HA fusion proteins
were subjected to 15% SDS-PAGE and stained with Coomassie blue (top), and with anti-HA (middle) or anti-NT (N-Tyr) antibody (bottom). Marker (M),
nitrated eGFP (N-GFP). (B) Identification SYN and N-SYN by MALDI-TOF-TOF MS. The prominent peak for SYN was 19682.10 m/z (theoretical m/z:
19806, mass accuracy: 0.6%; left-hand panel). The prominent peak for the modified protein, N-SYN, was 19846.25 m/z (theoretical m/z: 19806+45n,
where 1#n#8; right-hand panel) (C) Amino acid sequence of human a-synuclein (SNCA112). (D) Peptide fragments obtained from MS analysis that
match the sequence for unmodified or nitrated a-synuclein. (E) The difference in mass between two major nitrated fragments (right in E) and their
corresponding unmodified fragment (left in E) are shown in (F).
doi:10.1371/journal.pone.0009956.g001
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in the injected SNpc relative to the internal control SNpc 5 weeks
and 11 weeks after the injection (67.661.5% less at 5 weeks;
69.363.0% less at 11 weeks; Figure 8A and B), demonstrating the
efficacy of our delivery method. In contrast, injecting 2 mLo fN -
GFP (20 mmol/L) every day for 2 weeks did not significantly affect
the population of DA neurons in the SNpc 5 weeks or 11 weeks
later (8.064.0% reduction at 5 weeks; 11.065.1% reduction at 11
Figure 2. TAT-mediated internalization of fusion proteins into SHSY-5Y cells. SHSY-5Y cells were grown under standard culture conditions,
and then incubated with 0.1 mM of N-SYN (A–D), SYN (E–H) or N-GFP (I–L) for 20 min. All three HA-tagged (red; A, E and I) fusion proteins localized to
the cytoplasm. Nitration of N-SYN or SYN were determined by fluorescent labeling of anti-N-Tyr antibody (green; B and F). N-GFP proteins were
visualized by excitation of eGFP (green; J). The nuclei were stained with Hoechst (blue; C, G and K). Merged images are shown in (D), (H) and (L). Scale
bar, 50 mm.
doi:10.1371/journal.pone.0009956.g002
Figure 3. Intracellular but not extracellular N-SYN is detrimental to SHSY-5Y cells in a dose-dependent manner. (A) Graph showing
relative LDH release in response to treatment with various concentrations of the three fusion proteins. SHSY-5Y cells were incubated with the
indicated concentration of N-SYN, SYN or N-GFP. At each indicated incubation time point, equal aliquots of supernatant were collected and assayed
for LDH release. (B) SHSY-5Y cells were incubated with the indicated concentration of N-SYN
TAT2 or SYN
TAT2, fusion proteins that lack the TAT
peptide. N-SYN
TAT2 and SYN
TAT2 showed no apparent cytotoxicity to SHSY-5Y cells, as measured by LDH release. Data represent mean 6 SEM from
at least three independent experiments. **, p,0.01.
doi:10.1371/journal.pone.0009956.g003
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Relative to the N-GFP treatment, daily infusions of SYN (2 mLo f
20 mmol/L) for 2 weeks also did not have a significant effect on
DA neuron survival 5 weeks or 11 weeks later (13.465.4%
reduction at 5 weeks; 14.567.7% reduction at 11 weeks; Figure 8A
and B). Interestingly, 5 weeks after administration of N-SYN (2 mL
of 20 mmol/L), the number of TH-positive neurons in the SNpc
was reduced by a third (34.563.0%; Figure 8A, B and C), and 11
weeks after treatment the number was reduced even further
(48.764.1%; Figure 8A, B and D). These results demonstrate that
acute exposure to nitrated a-synuclein causes a long-lasting and
progressively more severe cytotoxic effect on DA neurons in the
SNpc of adult rats.
To ensure that loss of TH immunoreactivity was due to
neuronal loss and not a simply abandoning the function of
dopamine production, and to assess any potential toxicity on the
contralateral side (possibly due to inflammation), Nissl-positive and
TH-positive neurons were quantified on both sides in N-SYN
group (Figure 8E). Correlation analysis of total Nissl-positive
neurons compared to TH-positive and TH-negative neurons
demonstrated that the number of total neurons correlated with
numbers of TH-positive neurons compared to numbers of TH-
Figure 4. N-SYN induces apoptosis of SHSY-5Y cells. Apoptosis was determined by TUNEL staining after incubating SHSY-5Y cells with the
indicated concentration of N-SYN, SYN or N-GFP for 5 h. Representative images of cells in each treatment group are shown in (A). Typical apoptotic
cells (marked by asterisks) displayed chromatin condensation accompanied by shrinking of the soma (Hoechst, blue; TUNEL, red). (B) Quantification of
the proportion of apoptotic cells in each treatment group. Data are expressed as percent of TUNEL-positive vs. Hoechst-positive cells and presented
as mean 6 SEM from at least three independent experiments. *, p,0.05; **, p,0.01. Scale bar, 40 mm.
doi:10.1371/journal.pone.0009956.g004
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11 weeks). This confirmed that differences in TH-positive neuron
counts were due to differences in numbers of structurally intact
neurons and eliminated the possibility that differences resulted
from the down-regulation of TH itself. Also, quantification of
dopaminergic neurons on both ipsi- and contralateral sides were
not reminiscent of remarkable toxicity on the contralateral side
SNpc of rats in N-SYN group.
Further more, we found the GABAergic neurons of the
substantia nigra pars reticulata (SNpr) (Figure S2) and DA
neurons of VTA (data not shown) were spared in rat microinjected
with N-SYN for two weeks. These data support that SNpc DA
neurons are indeed more sensitive to N-SYN than the neighboring
GABAergic neurons in the SNpr or the DA neurons of VTA.
Immunostaining applying anti-HA antibody (Figure 7) ruled out
the possibility that the N-SYN did not reach the SNpr.
Figure 5. DAergic neurotoxicity induced by N-SYN. Primary cultures of mesencephalic cells incubated with the indicated concentration of N-
SYN, SYN or N-GFP for 48h were stained with anti-TH antibody, followed by Hoechst staining. (A) Representative images of cells from each treatment
group. (B) Quantification of the proportion of TH-positive DA neurons in each group. Data represent mean 6 SEM from three independent
experiments. *, p,0.05; **, p,0.01. Red, TH; blue, Hoechst. Scale bar, 40 mm.
doi:10.1371/journal.pone.0009956.g005
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could form intracellular aggregates in the substantial nigra.
Consistent with former reports [32], SYN infusion induced
aggregation intracellularly (Figure 9, arrows in lower panel).
Interestingly, we also found N-SYN infusion could induce a-
synuclein and Thioflavin-T positive intracellular aggregates
(Figure 9, arrows in upper panel).
Microglia and astrocyte were activated in the substantia
nigra of rat 5 weeks after N-SYN injection
Microglia and astrocyte were activated in the substantia nigra
of rat 5 weeks after N-SYN injection (Figure 10). Coronal VM
sections of N-SYN group rats showed loss of DA neurons
concurring with mounting microglia in substantia nigra of
ipsilateral side vs. that in substantia nigra of contralateral side.
More microglia exhibited activated morphology were found close
to atypical DA neurons on the N-SYN-injected side (Figure 10B,
D). Quantifications showed there were more Iba-1-positive
microglia on the N-SYN-injected side (66.569.9/mm
2) vs. those
on the non-injected contralateral side (21.563.8/mm
2, p,0.01)
(Figure 10H). Anti-GFAP immunostaining also showed the level
of GFAP expression in N-SYN group was augmented to 2.760.5
fold on the ipsilateral side vs. that on the contralateral side
(p,0.01) (Figure 10I). Thus, microglia and astrocyte were
activated in the substantia nigra of rat 5 weeks after N-SYN
injection.
N-SYN-treated rats show reduced locomotion in the
open field test
To determine the effect of N-SYN on locomotor and
exploratory behavior, we evaluated the performance of N-SYN-
and N-GFP-treated rats in an open field test (Figure 11A). N-
GFP, SYN or N-SYN (20 mmol/L) were injected unilaterally into
the SNpc daily for 2 weeks and then total distance traveled,
distance traveled in the center and distance traveled in the
periphery during a 15 min time period were measured.
Compared to the N-GFP-treated group, infusing N-SYN caused
significant decreases of more than 50% in all three parameters
(p,0.05, Figure 11B). Treating with SYN also significantly
reduced locomotion and exploratory behavior compared to the
N-GFP group (p,0.05, Figure 11B), but the reductions were
significantly less severe than in the N-SYN group. Overall active
time was concomitantly reduced in the N-SYN group, and to a
significantly greater degree than the SYN-treated group
Figure 6. Schematic time line of the experimental design. Stereotaxically administrations of N-SYN, SYN and N-GFP into the right substantia
nigra were processed from day 0 to 14, and single injection of 6-OHDA was processed on day 0. The open field test was conducted after 21 days post-
surgery. The rotorod test was conducted 1 day before and 21 days after stereological surgery. The rotation test was conducted on day 14, 21, 28, 35,
42, 77. Histology was processed on 5 weeks and 11 weeks postsurgery.
doi:10.1371/journal.pone.0009956.g006
Figure 7. TAT-mediated internalization of fusion proteins into substantia nigra of rats. N-SYN was stereotactically injected in the
substantia nigra of rats. After 24 hours, the nigral DA neurons were specifically labeled with anti-HA Ab (A, D) and anti-TH Ab (B, E). Detection with
anti-HA Ab revealed the fusion protein localized in almost all cells in SNpc, including DA neurons (C, F, merge) in the injected hemisphere. No anti-HA
staining was observed on the contralateral side (data not shown). SYN also localized in almost all cells in SNpc (data not shown). Scale bars: (A–C),
200 mm; (D-F), 50 mm.
doi:10.1371/journal.pone.0009956.g007
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distance traveled was the result of slow movements, we measured
the average velocity by dividing total distance traveled by the
active time. No significant decline in velocity was observed in the
N-SYN group (52.065.9 mm/s, p.0.05). To determine whether
N-SYN treatment affected the exploratory behavior, we calcu-
lated the distance traveled in the centre or periphery as a
percentage of total distance traveled. No statistical difference was
detected (data not shown). Together, these data suggest that N-
SYN-treated rats, by consistently failing to initiate voluntary
movement, exhibit reduced locomotion, which is a feature of PD
[38]. This impairment in mobility is possibly due to compromised
nigrostriatal functioning.
N-SYN-treated rats show impaired motor coordination in
the rotorod test
Gait disturbance and postural instability are also major motor
manifestations of PD [38]. We thus asked whether unilaterally
infusing N-SYN into the SNpc everyday for two weeks causes
motor coordination impairment. To evaluate neurotoxicity in a
Figure 8. Ipsilateral DA neuron lesions in the SNpc after N-SYN infusion. (A) Representative rat coronal sections showing populations of TH-
positive DA neurons in the SNpc 5 weeks and 11 weeks after ipsilateral infusion of 6-OHDA, N-SYN, SYN or N-GFP. Compared to the 6-OHDA as well as
to the N-SYN groups, DA neurons in the SYN and N-GFP groups were relatively spared. TH, green; Hoechst, blue. TH-positive DA neurons in the SNpc
were more vulnerable to N-SYN than SYN or N-GFP treatment (A, B). (B) Histograms showing the percentage of TH-positive DA neurons on the
injected side relative to that on the intact side 5 weeks and 11 weeks after rats were ipsilaterally infused with N-SYN, SYN, 6-OHDA or N-GFP. The
percent of TH-positive neurons from both infused and control sides of the SNpc were severely reduced in the 6-OHDA treated group (32.461.5% at 5
weeks; 30.763.0% at 11 weeks) and the N-SYN treated group (65.563.0% at 5 weeks; 51.364.0% at 11 weeks), but were mildly reduced in the SYN-
treated group (86.665.4% at 5 weeks; 85.567.7% at 11 weeks). (C) and (D) Representative rat coronal sections showing a substantially reduced
population of DA neurons in the SNpc 5 (C) and 11 (D) weeks after ipsilateral infusion of N-SYN. C5, C6, D5 and D6 show high magnification views of
the boxed area in C2, C4, D2 and D4, respectively. Hoechst staining (blue; C1, C3, D1 and D3) was conducted to rule out the possibility that the
reduction in TH-positive DA neurons was due to a reduction in the total number of cells in the detection area. (E) Further quantification of Nissl-
positive and TH-positive neurons on both ipsi- and contralateral sides of SNpc in N-SYN group. Scale bars: (A), 0.5 mm; (C), 50 mm; (D), 100 mm. Values
represent mean 6 SEM; **, p,0.01.
doi:10.1371/journal.pone.0009956.g008
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(green) were applied to detect aggregation after N-SYN or SYN treatment. a-Synuclein positive intracellular aggregates, which were also Thioflavin-T
positive, were formed after two weeks injection of N-SYN (arrows in upper panel). Similar aggregates were detected after two weeks injection of SYN
(arrows in lower panel). Scale bar: 25 mm.
doi:10.1371/journal.pone.0009956.g009
Figure 10. Increased microglia and astrocyte activation in the substantia nigra of rat in response to N-SYN. Coronal VM sections of N-
SYN group rats showed loss of DA neurons (TH, green) concurring with mounting microglia (Iba-1, red) in substantia nigra of ipsilateral side (B) vs.
that in substantia nigra of contralateral side (A). (C) and (D) representing a magnification of boxed area in (A) and (B), respectively. More microglia
exhibited activated morphology were found close to atypical DA neurons on the N-SYN-injected side (B, D). Quantifications showed there were more
Iba-1-positive microglia on the N-SYN-injected side (66.569.9/mm
2) vs. those on the non-injected contralateral side (21.563.8/mm
2, p,0.01) (H).
Scale bars: (A, B), 200 mm; (C, D), 50 mm. Coronal VM sections of N-SYN group rats showed astrocyte activation (GFAP, green) in SNpc of ipsilateral side
(E). (F) and (G) representing a magnification of boxed area in (E). Quantification of anti-GFAP immunostaining showed the level of GFAP expression in
N-SYN group was augmented to 2.760.5 fold on the ipsilateral side vs. that on the contralateral side (p,0.01) (I). Scale bars: (E), 800 mm; (F, G),
200 mm. Data represent mean 6 SEM from three independent experiments. **, p,0.01.
doi:10.1371/journal.pone.0009956.g010
TAT-N-SYN Damages DA Neurons
PLoS ONE | www.plosone.org 11 April 2010 | Volume 5 | Issue 4 | e9956nitrated a-synuclein lesion model in vivo, coordination and balance
was evaluated for the N-SYN group using the rotorod test. Latency
to fall from the rod, assessed as a function of both time (Figure 12A)
and rotational velocity (Figure 12B), was significantly reduced in the
N-SYN group compared to the N-GFP or SYN groups at the time
points throughout the entire span of the experiment (days 21 to 29
post-surgery; p,0.01). These results demonstrate that N-SYN
impairs motor coordination and balance.
Figure 11. Reduced locomotor activity of N-SYN-treated rats during the open field test. (A) Representative locomotor activity paths from
N-SYN, SYN and N-GFP groups are shown. (B) Rats from the N-SYN group exhibited reduced locomotor activity compared with those in the N-GFP
group. Total distance, distance traveled in centre, and distance traveled in the periphery for the N-SYN group were all significantly less than those of
the N-GFP group. (C) Active time for rats in the N-SYN group was less than that in the N-GFP group. Values represent mean 6 SEM; *, p,0.05;
**, p,0.01. n=8 per group.
doi:10.1371/journal.pone.0009956.g011
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test
Both N-SYN- and 6-OHDA-injected rats presented apomor-
phine (APO)-induced continuous unilateral rotational movement
two weeks after treatment (Figure 13A). Surprisingly, and contrary
to 6-OHDA which caused contralateral rotation, N-SYN treatment
caused continuous net ipsilateral rotation (the total number of
rotations in the ipsilateral or contralateral direction) at all time
points (Figure 13B), although a subset of rats were more tolerant to
N-SYN than the majority. This type of behavior is suggests
irreversible unilateral damage to the nigrostriatal DAergic pathway,
as has been described previously. No unilateral continuous rotation
was detected in rats treated with equivalent doses of SYN for
comparable time periods (data not shown). Thus, the nitrated form
a-synuclein is deleterious to the nigrostriatal system.
Dopamine D2 receptor is down-regulated and striatal DA
and DOPAC level is depleted by N-SYN
APO-induced contralateral rotation behavior seen in 6-OHDA-
lesioned rats is primarily mediated by the postsynaptic dopamine
Figure 12. Impairment of motor coordination in N-SYN-treated rats during the rotorod test. The motor defects caused by N-SYN
treatment were further assessed by comparing the latency to fall from the rotorod between rats from all four treatment groups (6-OHDA, N-SYN, SYN,
and N-GFP) at each indicated time point, before and after surgery. Latency to fall off the rotating rod was significantly reduced in the N-SYN group
relative to N-GFP or SYN groups at all time points. Values represent mean 6 SEM; **, p,0.01 vs. N-GFP; #, p,0.01 vs. SYN. n=8 per group.
doi:10.1371/journal.pone.0009956.g012
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underlying APO-induced rotation in rats treated with N-SYN,
we first determined the levels of D2R on both the injected and
intact sides of the striatum by immunoblotting 5 weeks post
surgery. In the N-SYN group, levels of D2R were significantly
lower on the treated side (right) of the striatum than that on the
intact side (left; Figure 14A). Quantification of band intensity
showed that D2R levels on the injected side were reduced to
26.164.7% of the intact side (Figure 14B). For D2R is present both
in pre- and post-synaptic populations in the striatum, levels of TH,
a presynaptic markers of nigrostriatal DA neurons, were further
detected. TH levels of the treated side were reduced to 78.963.2%
of the intact side (Figure 14C, D). Considering the discrepancy of
reduced levels between D2R and TH in striatum of N-SYN group,
we supposed that the decrease of D2R may be not only attributed
to down-regulation of presynaptic D2R but also to down-
regulation of post-synaptic D2R. Additionally, a milder decrease
in D2R levels was observed with SYN treatment (injected side
reduced to 59.563.3% of intact side; Figure 14A and B).
To further investigate the mechanisms underlying APO-
induced rotation, the lesion on the nigrostriatal DAergic pathway
at the striatal level was detected by measuring the striatal DA and
DOPAC level. N-SYN group displayed severe reduction in DA
and DOPAC compared with control (N-GFP group). At 5 weeks
post surgery, in N-SYN group, compared with the non-injected
side, level of DA and DOPAC on the injected side was depleted by
55.965.2% (p,0.01 compared with N-GFP) and 64.463.3%
(p,0.01 compared with N-GFP) respectively, while in SYN group,
level of DA and DOPAC was depleted by 86.064.7% (p,0.05
compared with N-GFP) and 81.262.8% (p,0.01 compared with
N-GFP) respectively (Figure 14E, F). Thus, N-SYN induced more
severe depletion of DA and DOPAC compared with SYN
treatment, which mirrored the loss of DA neurons at the same
time point (Figure 8B).
Discussion
Environmental factors, mitochondrial dysfunction, misfolded
protein aggregates, ubiquitin-proteasome system impairment, and
oxidative stress have all been implicated in the degeneration of DA
neurons that occurs in PD [41]. A number of nitrated proteins
have found to be associated with the pathogenesis of PD, including
protein kinase C [20], catecholamine [21], manganese superoxide
dismutase [22], a-synuclein [23,24,25], and others. However, no
direct evidence has shown whether and which nitrated protein(s)
is/are toxic to DAergic cells, thus contributing to the onset and
progression of PD. In the present study, we synthesized
recombinant a-synuclein in which all three tyrosine residues were
nitrated (N-SYN), consistent with the form of the protein that has
been identified in postmortem brain tissue of patients with PD
[23]. Using LDH and TUNEL assays, we demonstrated that N-
SYN was more cytotoxic to SHSY-5Y cells and DA neurons, both
in vivo and in vitro, than unnitrated SYN. Continual unilateral
infusion of N-SYN into the SNpc of rats caused chronic motor
deficits, such as low level of spontaneous activity, poor coordina-
tion and asymmetry, that were significantly more severe than
unnitrated SYN but milder than those caused by injecting 6-
OHDA into the SNpc. The neurotoxic effects of N-SYN on DA
neurons of the SNpc, combined with behavior deficits that we
observed, strongly suggest that is sufficient to cause a PD-like
disorder in rats. Thus, our study provides the first evidence that
nitrated a-synuclein can induce the death of DA neurons.
Although a-synuclein is ubiquitously expressed and Lewy
pathology has been detected throughout the CNS and peripheral
autonomic nervous system, compared with other cell types, DA
neurons in the substantia nigra are highly susceptible in PD
associated pathology. As an example of this selectivity, transfecting
human a-synuclein into the substantia nigra of rats selectively
damages the nigrostriatal DA system, despite high levels of
transgene expression in non-DA neurons [42]. As DA metabolism
generates high concentrations of reactive oxygen species/reactive
nitrogen species (ROS/RNS) [43,44], we suggest that the
interaction between a-synuclein and ROS/RNS in DA neurons
contributes to selective nigrostriatal neurodegeneration in PD. In
the presence of metal, a-synuclein has been found to become even
more toxic to DAergic cells, likely due to increased rates of ROS/
RNS formation [43,45]. On the other hand, a-synuclein-deficient
mice are resistant to toxicity induced by MPTP and other
mitochondrial toxins [46,47]. Moreover, a-synuclein in its fully
nitrated form (i.e. nitrated at all three of its tyrosine residues) is
considered a marker for oxidative and nitrative stress, and has
been found to accumulate in the filamentous building blocks of
Lewy bodies in PD [23]. These findings and others, combined
with the results presented herein, strongly suggest that both RNS
and a-synuclein are major factors in the pathogenesis of PD. What
then, might render nitrated a-synuclein more toxic to DA
neurons? Although the mechanism remains unclear, several
possibilities have been proposed. These include: (1) nitration
inhibits fibrillation of human a-synuclein in vitro by forming stable
soluble oligomers or protofibrils [24,48,49]; (2) nitration reduces
the association of a-synuclein with lipid vesicles, prolonging its
intracellular half-life [50], thus increasing cytosolic concentrations
that possibly cause and exacerbate ER-Golgi traffic blocks [51];
and (3) nitrated a-synuclein may contribute to the formation of
annular protofibrils that resemble a class of pore-forming bacterial
toxins [52].
Nitrated tyrosine (NT) modifications in a-synuclein do not seem
to occur merely at the very end stage of PD. Our in vitro and in vivo
observations support the idea that nitrated a-synuclein itself
directly contributes to the DAergic neurodegeneration that occurs
during the progression of PD. Recent studies [25,53] have shown
that increased nitration of tyrosine residues in a-synuclein induce
immune responses that intensify PD progression. In the present
study, we found that intracellular nitrated a-synuclein can cause a
rapid DAergic cell apoptosis response in vitro, independent of an
Figure 13. Rats treated with N-SYN display motor asymmetry
induced by apomorphine. Motor asymmetry was assessed by
administrating apomorphine (APO; 0.5 mg/kg) at the indicated time
point after 6-OHDA or N-SYN infusion. Contrarily to 6-OHDA treatment,
which caused contralateral rotation, rats in the N-SYN group showed
continuous ipsilateral rotation. Values represent mean 6 SEM. n=8–11
per group.
doi:10.1371/journal.pone.0009956.g013
TAT-N-SYN Damages DA Neurons
PLoS ONE | www.plosone.org 14 April 2010 | Volume 5 | Issue 4 | e9956immune response. Although this result does not rule out the role
for N-SYN in the activation of microglia or T cell immunoreac-
tivity, this finding suggests nitrated a-synuclein is sufficient to kill
DA neurons in a cell autonomous manner. Thereupon, nitrated a-
synuclein inclusions would be phagocytosed by microglia or
presented to T cell lymphocytes [25,53,54] causing neuroinflam-
mation and immune responses which may induce additional a-
synuclein nitration due to a burst in the production of free radicals
[55,56]. This would in turn aggravate DA neuron loss.
In this study, we didn’t observe remarkable toxicity with SYN
infusion at the level of SNpc, which was not consistent with Kirik’s
study using adeno-associated viral vectors [12]. It could be
attributed to several factors, including: (1) whether the a-synuclein
is adequately delivered to substantia nigra; (2) whether DA neuron
is more sensitive to intracellular expressed a-synuclein mediated
by viral infection. There are four transcript variants of a-synuclein
described so far. Among these variants, SNCA112, with a
shortening of the C-terminal, is surmised to have increased
propensity to aggregate and is over-expressed in dementia with
Lewy bodies compared with full-length a-synuclein [57]. Consid-
ering the absence of a site important for the inhibition of a-
synuclein fibril formation, SNCA112 may increase its propensity
to fibrillize into a less noxious form [58]. Thus a-synuclein tested
in this study may have less toxicity compared with a-synuclein
used in Kirik’s study.
Though less toxic than N-SYN, the SYN in itself is toxic, and
induces nigrastriatal degeneration when overloaded. It can be
attributed to several factors, including: (1) SYN may inhibit
proteasomal function and induces protein degradation failure
when overloaded intracellularly; (2) SYN can be modified into
Figure 14. Dopamine D2 receptor is downregulated and striatal DA and DOPAC level is depleted by N-SYN. (A) Western blot showing
dopamine D2 receptor (D2R) protein levels in the striatum of N-SYN- or SYN-treated rats five weeks postsurgery. GAPDH was used as a loading
control. (B) Graph showing the relative levels of D2R (injected side vs. intact side) in the striatum of N-SYN- and SYN-treated rats. N-SYN and SYN
treatment induced the down-regulation of D2R to 26.164.7% and 59.563.3% of control, respectively. (C) Further comparison of Tyrosine hydroxylase
(TH) and D2R protein levels in bilateral striatum of N-SYN-treated rats by Western blot. (D) Graph showing the relative levels of D2R and TH (injected
side vs. intact side) in the striatum of N-SYN-treated rats. N-SYN treatment induced the down-regulation of TH to 78.963.2% of control. Values
represent mean 6 SEM. ** p,0.01, n=4 per group. L, left; R, right. The amounts of DA and DOPAC in striatal tissue were measured on the injected
and uninjected sides of individual animals in N-SYN, SYN and control (N-GFP) as described in Materials and Methods and were displayed as the
average striatal concentration of DA (E) and DOPAC (F) on both ipsi- and contralateral sides. Values represent mean 6 SEM. * p,0.05, ** p,0.01, n=3
per group.
doi:10.1371/journal.pone.0009956.g014
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other endogenous oxidative compounds, and aggravates nigrostri-
atal degeneration.
Administration of 6-OHDA to the SNpc is a routine procedure
for generating rodent Parkinsonian models [59]. There are several
shortcomings to the 6-OHDA model of PD, however, including
the unnaturally acute damage that 6-OHDA causes, and the lack
of evidence that 6-OHDA is detected in DA neurons in the
pathogenesis of PD. In this study, N-SYN emerged as a novel
candidate with which to develop a new molecular model for PD.
Using N-SYN to model PD pathogenesis offers two major
advantages: N-SYN is found in ventral mesencephalic DA neurons
of PD patients and is considered a critical factor in PD
development [23,25], thus providing a pathophysiological basis
for this model; and, as we showed herein, nitrated a-synuclein
affects DA neuron less severely and causes less acute lesions than
6-OHDA in vivo. Thus, the N-SYN administration paradigm we
used herein, which caused a slower and milder, and thus more
physiologically relevant, development of Parkinsonian lesions and
behaviors, validates its use as a potentially in vivo model of PD,
particularly on studying the toxicity of PD associated protein
modification.
The results of our rotation tests revealed that ipsilateral
administration of N-SYN to the SNpc of adult rats caused the
animals to continuously rotate ipsilateral to the lesioned side after
apomorphine induction, and a concomitant ipsilateral down-
regulation of post-synaptic D2R within the striatum. It has
previously been shown that TH-positive nerve terminals within
the striatum are reduced in transgenic mice overexpressing a-
synuclein [13], and D2R is downregulated in some neurodegen-
erative diseases [60]. Recently, de Oliveira et al. reported that
D2R down-regulation occurred together with the upregulation of
3-nitrotyrosine and a-synuclein in a rodent oxidative stress model
[61], although no cause-effect relationship was ascertained. In this
study, we demonstrated that N-SYN not only led to the death of
DA neurons in the SNpc, but also to a down-regulation of D2Ri n
the striatum. We hypothesize that nitrated a-synuclein triggered
DA neuron dystrophy in the SNpc, leading to the retraction of the
spines and dispersal of post-synaptic machinery (including D2R
receptors) on dendrites of downstream striatal projection neurons
[62]. Considering behavioral and histological data in our study
showing N-SYN caused milder lesion to DA neurons in the SNpc
than 6-OHDA and the data from HPLC indicating striatal
dopamine depletion in N-SYN-treated rats, another possible
explanation may be that as described previously [63]: The
difference in rotation behavior was caused by differences in the
magnitude of the nigrostriatal lesion. It was the milder lesion of
DA neurons in the SNpc that depleted striatal dopamine, reduced
the binding of D1 receptors in the ipsilateral striatum and
subsequently caused apomorphine induced ipsilateral rotation.
Further study is needed to elucidate the exact role of dopamine
receptors, including D1R and D2R, in the rotation behavior.
In summary, we here provide evidence to show that a-synuclein
exclusively in its nitrated form is sufficient to cause the death of
SNpc DA neurons in a cell autonomous manner in vitro, and to
cause lesions in the SNpc and behavior deficits that resemble those
suffered by patients with PD. This study opens new avenues to
study the role of specific protein modification in neurodegener-
ative disease.
Supporting Information
Figure S1 N-SYN induces protein aggregation and apoptotic
cell death of SHSY-5Y cells. Immunostaining with anti-HA
antibody (red) and TUNEL (green) revealed that some TUNEL (+)
apoptotic cells contained intracellular aggregates (arrow), but some
TUNEL (+) apoptotic cells didn’t contain aggregates (arrow head).
Additionally, some cells contained HA (+) aggregates with
TUNEL (2) (asterisk). Scale bar: 10 mm.
Found at: doi:10.1371/journal.pone.0009956.s001 (1.40 MB TIF)
Figure S2 GABAergic neurons in the substantia nigra reticular
(SNpr) were spared in N-SYN treated rats 11 weeks post injection.
TH (green, dopaminergic) and glutamic acid decarboxylase (GAD)
(red, GABAergic) immunostaining of SN showed loss of
dopaminergic but not of GABAergic neurons after microinjections
with N-SYN (right side) for two weeks. Scale bars: (A), 500 mm; (B,
C), 200 mm; (D, E), 100 mm.
Found at: doi:10.1371/journal.pone.0009956.s002 (4.82 MB TIF)
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